Your new experience awaits. Try the new design now and help us make it even better

MINI REVIEW article

Front. Nephrol.

Sec. Clinical Research in Nephrology

Volume 5 - 2025 | doi: 10.3389/fneph.2025.1624586

This article is part of the Research TopicCystinosis Symposium: A Rare Disease Model for Comprehensive CareView all 5 articles

The Assessment and Treatment of the Musculoskeletal Manifestations of Cystinosis

Provisionally accepted
  • Montefiore Health System, The Bronx, United States

The final, formatted version of the article will be published soon.

Cystinosis is a rare autosomal recessive lysosomal storage disease caused by a defective lysosomal cystine carrier protein, cystinosin, resulting in formation and deposition of cystine crystals throughout the body. The renal manifestations of the disease have long been studied, but the musculoskeletal consequences of the disease are generally less well understood. Limb deformities, scoliosis, myopathy and low bone mineral density are associated with cystinosis and can lead to pain, fragility fractures, bone deformity, and difficulty ambulating. Although potentially exacerbated by renal disease and post-transplant medications, it has been found that the musculoskeletal manifestations of cystinosis are also due to inherent dysfunction caused by the mutation of cystinosin. Surgical intervention can provide solutions to the bony symptoms of cystinosis. Early referral to an orthopaedic surgeon and evaluation for corrective scoliosis surgery, guided growth for growing children with lower extremity deformity and formal osteotomies for deformity correction in skeletally mature individuals may improve physical function and decrease pain. Standard principles of operative treatment of scoliosis and of bone deformity correction utilized for the treatment of bone deformity in other metabolic bone disease may be applied to patients with cystinosis in the absence of cystinosis-specific studies of the efficacy and outcomes of orthopaedic surgery.

Keywords: Scoliosis, Myopathy, Low bone mineral density, Fragility fractures, Bone deformity, Renal Osteodystrophy, Long bone fractures, vertebral insufficiency fractures

Received: 07 May 2025; Accepted: 27 Aug 2025.

Copyright: © 2025 Singh, Marsh and Sharkey. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Priya Singh, Montefiore Health System, The Bronx, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.